Fujiwara Keiichi

Papers (25)：

Ikeda Y, Hasegawa K, Kurosaki A, Miyara A, Hanaoka T, Shintani D, Imai Y, Nishikawa T, Oda K, Fujiwara K. The Risk of Ovarian Malignancy Algorithm (ROMA) as a Predictive Marker of Peritoneal Dissemination in Epithelial Ovarian Cancer Patients. Oncol Res Treat. 2015. 38. 6. 276-281
Yasutsuna Sasaki, Keisuke Miwa, Keishi Yamashita, Yu Sunakawa, Ken Shimada, Hiroo Ishida, Kosei Hasegawa, Keiichi Fujiwara, Makoto Kodaira, Yasuhiro Fujiwara, et al. A phase I study of farletuzumab, a humanized anti-folate receptor alpha monoclonal antibody, in patients with solid tumors. INVESTIGATIONAL NEW DRUGS. 2015. 33. 2. 332-340
Koji Matsuo, Kiyoshi Yoshino, Kosei Hasegawa, Ryusuke Murakami, Yuji Ikeda, Sosuke Adachi, Kosuke Hiramatsu, Takuhei Yokoyama, Masato Nishimura, Todd B. Sheridan, et al. Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion. GYNECOLOGIC ONCOLOGY. 2015. 136. 2. 198-204
Nagao S, Nishikawa T, Hanaoka T, Kurosaki A, Iwasa N, Hasegawa K, Fujiwara K. Feasibility Study of Combination Chemotherapy with Paclitaxel, Doxorubicin and Cisplatin without Prophylactic Granulocyte Colony-stimulating Factor Injection for Intermediate-to-high Risk or Recurrent Endometrial Cancer. Jpn J Clin Oncol. 2014. 44. 11. 1040-1044
Hasegawa K, Nagao S, Yasuda M, Millan D, Viswanathan AN, Glasspool RM, Devouassoux-Shisheboran M, Covens A, Lorusso D, Kurzeder C, et al. Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Uterine Corpus and Cervix. Int J Gynecol Cancer. 2014. 24. 9 Suppl 3. s90-s95

ｍore...

Professional career (1)：

PhD (Okayama Univeristy)

Committee career (7)：

2012/12 - 現在 JGOG 副理事長
2009/02 - 現在 GOTIC 副理事長
2012/01 - 2014/12 International Society of Gynecologic Cancer
2012/01 - 2014/12 International Society of Gynecologic Cancer Secretary Treasurer
2014/04 - 先進医療評価会議委員委員

Show all

Association Membership(s) (1)：

International Society of Gynecologic Cancer

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page